Ads
related to: lung cancer- Metastatic NSCLC Info
Find Information About
ALK+ Metastatic NSCLC
- Financial Support
Find Financial Support Options For
Your Patients With ALK+ mNSCLC
- Therapy Management
Review Therapy Management
Strategies For An ALK+ mNSCLC Rx
- Prescribing Information
See Full Prescribing Info For
An ALK+ mNSCLC Rx Option
- First Line mNSCLC Rx
Find Rx Info For A First Line ALK+
Metastatic NSCLC Treatment Option
- Patient Website
Find Info and Resources
On The Patient Website
- Metastatic NSCLC Info
Search results
Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study
Bloomberg· 6 days agoSummit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its...
Stress from living in violent neighborhoods tied to aggressive lung cancer in Black men
Medical Xpress· 2 days agoExposure to increased neighborhood violence has the power to change the glucocorticoid receptor (GR)...
Newswise Expert | Puneeth Iyengar, UT Southwestern Medical Center
Newswise· 23 hours agoBriefly, Puneeth Iyengar joined the UT Southwestern Medical Center in Dallas, TX USA in the summer of 2010 and is currently an Assistant Professor of Radiation Oncology, with a professional ...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 5 days ago, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer and...
Strong Trial Results For Pfizer Lung Cancer Drug
International Business Times· 6 days agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung ...
Unprecedented PFS Results in ALK-Positive Lung Cancer Trial
MedPage Today· 6 days agoFive-year results from a phase III trial had experts gushing over lorlatinib's (Lorbrena)...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 5 hours agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 5 days agoHave a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 5 days agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
Review | Celebrating the glamorous heyday of the department store
Washington Post· 13 hours agoEmile Zola rhapsodized on the Parisian department store in “The Ladies’ Paradise.” Edith Wharton’s...
Ads
related to: lung cancer